Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma

Stopped Abandon of study

Conditions

• Hepatocellular Carcinoma

Interventions

• OTHER: patients with hepatocellular carcinoma

Sponsor

Assistance Publique - Hôpitaux de Paris